Result:Good#Margin expansion#Base effect
| Metric | Value (₹ Cr) | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 154.73 | 5.9% | 12.0% |
| Total Income | 155.82 | 5.9% | 11.9% |
| Expenditure | 137.06 | 10.8% | 0.4% |
| PBT | 18.76 | 56.9% | 1003.5% |
| Net Profit | 14.02 | 58.2% | 1078.2% |
| OPM | 13.31% | 4.98pp | 10.23pp |
| NPM | 9.00% | 3.65pp | 8.15pp |
| EPS | 13.57 | 58.2% | 1080.0% |
Chemicals: revenue grew a moderate 12% YoY while OPM expanded sharply from 3.1% to 13.3% driving PAT to ₹14cr, but the 1078% PAT growth is off an unusually depressed prior-year base, so this reads as margin normalization/expansion rather than a top-tier standout.
Informational and educational content only. Not investment advice.